The ACE gene and human performance: 12 Years on

Sports Medicine

Volumn 41, Issue 6, 2011, Pages 433-448

  Puthucheary, Zudin ^a   Skipworth, James R A ^a   Rawal, Jai ^a   Loosemore, Mike ^a,b   Van Someren, Ken ^a,b   Montgomery, Hugh E ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ENGLISH INSTITUTE OF SPORT   (United Kingdom)

Author keywords

Exercise; Genetic polymorphism; Sports

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ATHLETE; ATHLETIC PERFORMANCE; ENDURANCE; EXERCISE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; PHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SKELETAL MUSCLE;

ATHLETES; ATHLETIC PERFORMANCE; EXERCISE; GENOTYPE; HUMANS; MUSCLE, SKELETAL; PEPTIDYL-DIPEPTIDASE A; PHYSICAL ENDURANCE; POLYMORPHISM, GENETIC; RENIN-ANGIOTENSIN SYSTEM;

EID: 79957601052     PISSN: 01121642     EISSN: 11792035     Source Type: Journal    
DOI: 10.2165/11588720-000000000-00000     Document Type: Review

References (162)

1. Montgomery HE, Marshall R, HemingwayH, et al. Human gene for physical performance. Nature 1998; 393 (6682): 221-2.
2. Timmermans PB, Smith RD. Angiotensin II receptor subtypes: selective antagonists and functional correlates. Eur Heart J 1994; 15 Suppl. D: 79-87.
3. Dendorfer A, Wolfrum S,WagemannM, et al. Pathways of bradykinin degradation in blood and plasma of normotensive and hypertensive rats. Am J Physiol Heart Circ Physiol 2001; 280 (5): H2182-8.
4. Regoli D, Nsa Allogho S, Rizzi A, et al. Bradykinin receptors and their antagonists. Eur J Pharmacol 1998; 348 (1): 1-10. (Pubitemid 28266747)
5. Brown NJ, Blais Jr C, Gandhi SK, et al. ACE insertion/deletion genotype affects bradykinin metabolism. J Cardiovasc Pharmacol 1998; 32 (3): 373-7. (Pubitemid 28399665)
6. Murphey LJ, Gainer JV, Vaughan DE, et al. Angiotensinconverting enzyme insertion/deletion polymorphism modulates the human in vivo metabolism of bradykinin. Circulation 2000; 102 (8): 829-32.
7. Kem DC, Brown RD. Renin: from beginning to end. N Engl J Med 1990; 323 (16): 1136-7.
8. Dzau VJ. Multiple pathways of angiotensin production in the blood vessel wall: evidence, possibilities and hypotheses. J Hypertens 1989; 7 (12): 933-6. (Pubitemid 20106526)
9. Nazarov IB, Woods DR, Montgomery HE, et al. The angiotensin converting enzyme I/D polymorphism in Russian athletes. Eur J Hum Genet 2001; 9 (10): 797-801. (Pubitemid 33014594)
10. Paul M, Poyan Mehr A, Kreutz R. Physiology of local renin- angiotensin systems. PhysiolRev 2006; 86 (3): 747-803. (Pubitemid 44033382)
11. Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86 (4): 1343-6.
12. Costerousse O, Allegrini J, Lopez M, et al. Angiotensin Iconverting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J 1993; 290 (Pt 1): 33-40. (Pubitemid 23081197)
13. Danser AH, Schalekamp MA, Bax WA, et al. Angiotensinconverting enzyme in the human heart: effect of the deletion/insertion polymorphism. Circulation 1995; 92 (6): 1387-8.
14. Villard E, Tiret L, Visvikis S, et al. Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis. Am J Hum Genet 1996; 58 (6): 1268-78.
15. Jeunemaitre X, Lifton RP, Hunt SC, et al. Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nat Genet 1992; 1 (1): 72-5.
16. Jeunemaitre X, Rigat B, Charru A, et al. Sib pair linkage analysis of renin gene haplotypes in human essential hypertension. Hum Genet 1992; 88 (3): 301-6.
17. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71 (1): 169-80.
18. Ishigami T, Umemura S, Tamura K, et al. Essential hypertension and 50 upstream core promoter region of human angiotensinogen gene. Hypertension 1997; 30 (6): 1325-30.
19. Sato N, Katsuya T, Rakugi H, et al. Association of variants in critical core promoter element of angiotensinogen gene with increased risk of essential hypertension in Japanese. Hypertension 1997; 30 (3 Pt 1): 321-5. (Pubitemid 27446087)
20. Inoue I, Nakajima T, Williams CS, et al. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 1997; 99 (7): 1786-97.
21. Paillard F, Chansel D, Brand E, et al. Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population. Hypertension 1999; 34 (3): 423-9. (Pubitemid 29426758)
22. Mansego ML, Redon J, Marin R, et al. Renin polymorphisms and haplotypes are associated with blood pressure levels and hypertension risk in postmenopausal women. J Hypertens 2008; 26 (2): 230-7.
23. Poirier O, Georges JL, Ricard S, et al. New polymorphisms of the angiotensin II type 1 receptor gene and their associations with myocardial infarction and blood pressure: the ECTIM study. Etude Cas-Temoin de l'Infarctus du Myocarde. J Hypertens 1998; 16 (10): 1443-7.
24. Miller JA, Thai K, Scholey JW. Angiotensin II type 1 receptor gene polymorphism predicts response to losartan and angiotensin II. Kidney Int 1999; 56 (6): 2173-80.
25. Bonnardeaux A, Davies E, Jeunemaitre X, et al. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 1994; 24 (1): 63-9. (Pubitemid 24195405)
26. Martin MM, Elton TS. The sequence and genomic organization of the human type 2 angiotensin II receptor. Biochem Biophys Res Commun 1995; 209 (2): 554-62.
27. Alhenc-Gelas F, Richard J, Courbon D, et al. Distribution of plasma angiotensin I-converting enzyme levels in healthymen: relationship to environmental and hormonal parameters. J Lab Clin Med 1991; 117 (1): 33-9.
28. Woods D, Onambele G, Woledge R, et al. Angiotensin-I converting enzyme genotype-dependent benefit from hormone replacement therapy in isometric muscle strength and bone mineral density. J Clin Endocrinol Metab 2001; 86 (5): 2200-4. (Pubitemid 32472940)
29. Myerson S, Hemingway H, Budget R, et al. Human angiotensin I-converting enzyme gene and endurance performance. J Appl Physiol 1999; 87 (4): 1313-6.
30. Tsianos G, Sanders J, Dhamrait S, et al. The ACE gene insertion/deletion polymorphism and elite endurance swimming. Eur J Appl Physiol 2004; 92 (3): 360-2. (Pubitemid 39117500)
31. Gayagay G, Yu B, Hambly B, et al. Elite endurance athletes and the ACE I allele: the role of genes in athletic performance. Hum Genet 1998; 103 (1): 48-50. (Pubitemid 28398384)
32. Alvarez R, Terrados N, Ortolano R, et al. Genetic variation in the renin-angiotensin system and athletic performance. Eur J Appl Physiol 2000; 82 (1-2): 117-20. (Pubitemid 30312852)
33. CollinsM, Xenophontos SL, Cariolou MA, et al. The ACE gene and endurance performance during the South African Ironman Triathlons. Med Sci Sports Exerc 2004; 36 (8): 1314-20.
34. Woods D, Hickman M, Jamshidi Y, et al. Elite swimmers and the D allele of the ACE I/D polymorphism. Hum Genet 2001; 108 (3): 230-2. (Pubitemid 32293669)
35. Costa A, Silva A, Garrido N, et al. Association between ACE D allele and elite short distance swimming. Eur J Appl Physiol 2009; 106 (6): 785-90.
36. Rankinen T, Wolfarth B, Simoneau JA, et al. No association between the angiotensin-converting enzyme ID polymorphism and elite endurance athlete status. J Appl Physiol 2000; 88 (5): 1571-5.
37. Montgomery H, Dhamrait S. ACE genotype and performance. J Appl Physiol 2002; 92 (4): 1774-5; author reply 1776-7.
38. Woods DR, Humphries SE, Montgomery HE. The ACE I/D polymorphism and human physical performance. Trends Endocrinol Metab 2000; 11 (10): 416-20.
39. Sonna LA, Sharp MA, Knapik JJ, et al. Angiotensinconverting enzyme genotype and physical performance during US Army basic training. J Appl Physiol 2001; 91 (3): 1355-63.
40. Karjalainen J, Kujala UM, Stolt A, et al. Angiotensinogen gene M235T polymorphism predicts left ventricular hypertrophy in endurance athletes. J Am Coll Cardiol 1999; 34 (2): 494-9.
41. Taylor RR, Mamotte CD, Fallon K, et al. Elite athletes and the gene for angiotensin-converting enzyme. J Appl Physiol 1999; 87 (3): 1035-7.
42. Amir O, Amir R, Yamin C, et al. The ACE deletion allele is associated with Israeli elite endurance athletes. Exp Physiol 2007; 92 (5): 881-6. (Pubitemid 47283915)
43. Zoossmann-Diskin A. The association of the ACE gene and elite athletic performance in Israel may be an artifact. Exp Physiol 2008; 93 (11): 1220; author reply 1221.
44. Kim CH, Cho JY, Jeon JY, et al. ACE DD genotype is unfavorable to Korean short-term muscle power athletes. Int J Sports Med 2010; 31 (1): 65-71.
45. Cam FS, Colakoglu M, Sekuri C, et al. Association between the ACE I/D gene polymorphism and physical performance in a homogeneous non-elite cohort. Can J Appl Physiol 2005; 30 (1): 74-86. (Pubitemid 40313622)
46. Cerit M, Colakoglu M, Erdogan M, et al. Relationship between ace genotype and short duration aerobic performance development. Eur J Appl Physiol 2006; 98 (5): 461-5. (Pubitemid 44873303)
47. Colakoglu M, Cam FS, Kayitken B, et al. ACE genotype may have an effect on single versus multiple set preferences in strength training. Eur J Appl Physiol 2005; 95 (1): 20-6. (Pubitemid 43008892)
48. Juffer P, Furrer R, Gonzalez-Freire M, et al. Genotype distributions in top-level soccer players: a role for ACE? Int J Sports Med 2009; 30 (5): 387-92.
49. Lucia A, Gomez-Gallego F, Chicharro JL, et al. Is there an association between ACE and CKMM polymorphisms and cycling performance status during 3-week races? Int J Sports Med 2005; 26 (6): 442-7. (Pubitemid 41117062)
50. Muniesa CA, Gonzalez-Freire M, Santiago C, et al. Worldclass performance in lightweight rowing: is it genetically influenced? A comparison with cyclists, runners and nonathletes. Br J Sports Med 2010; 44 (12): 898-901.
51. Winnicki M, Accurso V, Hoffmann M, et al. Physical activity and angiotensin-converting enzyme gene polymorphism in mild hypertensives. Am J Med Genet A 2004; 125A (1): 38-44. (Pubitemid 38166531)
52. Costa AM, Silva AJ, Garrido ND, et al. Association between ACE D allele and elite short distance swimming. Eur J Appl Physiol 2009; 106 (6): 785-90.
53. Giaccaglia V, Nicklas B, Kritchevsky S, et al. Interaction between angiotensin converting enzyme insertion/deletion genotype and exercise training on knee extensor strength in older individuals. Int J Sports Med 2008; 29 (1): 40-4. (Pubitemid 351183238)
54. Zhao B, Moochhala SM, Tham S, et al. Relationship between angiotensin-converting enzyme ID polymorphism and VO(2max) of Chinese males. Life Sci 2003; 73 (20): 2625-30.
55. Tsianos G, Eleftheriou KI, Hawe E, et al. Performance at altitude and angiotensin I-converting enzyme genotype. Eur J Appl Physiol 2005; 93 (5-6): 630-3. (Pubitemid 40443781)
56. Hruskovicova H, Dzurenkova D, Selingerova M, et al. The angiotensin converting enzyme I/D polymorphism in long distance runners. J Sports Med Phys Fitness 2006; 46 (3): 509-13. (Pubitemid 44606465)
57. Cieszczyk P, Krupecki K, Maciejewska A, et al. The angiotensin converting enzyme gene I/D polymorphism in polish rowers. Int J Sports Med 2009; 30 (8): 624-7.
58. Min SK, Takahashi K, Ishigami H, et al. Is there a gender difference between ACE gene and race distance? Appl Physiol Nutr Metab 2009; 34 (5): 926-32.
59. Cam S, Colakoglu M, Colakoglu S, et al. ACE I/D gene polymorphism and aerobic endurance development in response to training in a non-elite female cohort. J Sports Med Phys Fitness 2007; 47 (2): 234-8.
60. Moran CN, Vassilopoulos C, Tsiokanos A, et al. The associations of ACE polymorphisms with physical, physiological and skill parameters in adolescents. Eur J Hum Genet 2006; 14 (3): 332-9.
61. Thompson J, Raitt J, Hutchings L, et al. Angiotensinconverting enzyme genotype and successful ascent to extreme high altitude. High AltMed Biol 2007; 8 (4): 278-85. (Pubitemid 350274421)
62. Hurlbut DE, Lott ME, Ryan AS, et al. Does age, sex, or ACE genotype affect glucose and insulin responses to strength training? J Appl Physiol 2002; 92 (2): 643-50. (Pubitemid 34671032)
63. Dekany M, Harbula I, Berkes I, et al. The role of insertion allele of angiotensin converting enzyme gene in higher endurance efficiency and some aspects of pathophysio- logical and drug effects. Curr Med Chem 2006; 13 (18): 2119-26.
64. WilliamsAG,RaysonMP, Jubb M, et al. TheACE gene and muscle performance [letter]. Nature 2000; 403 (6770): 614. (Pubitemid 30103990)
65. Kritchevsky SB, Nicklas BJ, Visser M, et al. Angiotensinconverting enzyme insertion/deletion genotype, exercise, and physical decline. JAMA 2005; 294 (6): 691-8. (Pubitemid 41159288)
66. Goh KP, Chew K, Koh A, et al. The relationship between ACE gene IDpolymorphism and aerobic capacity in Asian rugby players. Singapore Med J 2009; 50 (10): 997-1003.
67. Turgut G, Turgut S, Genc O, et al. The angiotensin converting enzyme I/D polymorphism in Turkish athletes and sedentary controls. Acta Medica (Hradec Kralove) 2004; 47 (2): 133-6.
68. Scott RA, Irving R, Irwin L, et al. ACTN3 and ACE genotypes in elite Jamaican and US sprinters. Med Sci Sports Exerc 2010; 42 (1): 107-12.
69. Frederiksen H, Bathum L, Worm C, et al. ACE genotype and physical training effects: a randomized study among elderly Danes. Aging Clin Exp Res 2003; 15 (4): 284-91. (Pubitemid 37441513)
70. Scott RA, Moran C, Wilson RH, et al. No association between angiotensin converting enzyme (ACE) gene variation and endurance athlete status in Kenyans. Comp Biochem Physiol A Mol Integr Physiol 2005; 141 (2): 169-75. (Pubitemid 40965749)
71. Day SH, Gohlke P, Dhamrait SS, et al. No correlation between circulating ACE activity and . VO2max or mechanical efficiency in women. Eur J Appl Physiol 2007; 99 (1): 11-8. (Pubitemid 44782937)
72. Oh SD. The distribution of I/D polymorphism in the ACE gene among Korean male elite athletes. J Sports Med Phys Fitness 2007; 47 (2): 250-4.
73. Papadimitriou ID, Papadopoulos C, Kouvatsi A, et al. The ACE I/D polymorphism in elite Greek track and field athletes. J Sports Med Phys Fitness 2009; 49 (4): 459-63.
74. Thomis MA, Huygens W, Heuninckx S, et al. Exploration of myostatin polymorphisms and the angiotensin-converting enzyme insertion/deletion genotype in responses of human muscle to strength training. Eur J Appl Physiol 2004; 92 (3): 267-74. (Pubitemid 39117488)
75. McCauley T, Mastana SS, Hossack J, et al. Human angiotensin-converting enzyme I/D and alpha-actinin 3 R577X genotypes and muscle functional and contractile properties. Exp Physiol 2009; 94 (1): 81-9.
76. Bennani-Baiti IM, Jones BK, Liebhaber SA, et al. Physical linkage of the human growth hormone gene cluster and the skeletal muscle sodium channel alpha-subunit gene (SCN4A) on chromosome 17. Genomics 1995; 29 (3): 647-52.
77. Hasegawa Y, Fujii K, Yamada M, et al. Identification of novel human GH-1 gene polymorphisms that are associated with growth hormone secretion and height. J Clin Endocrinol Metab 2000; 85 (3): 1290-5.
78. Walpole B, Noakes TD, Collins M. Growth hormone 1 (GH1) gene and performance and post-race rectal temperature during the South African Ironman triathlon. Br J Sports Med 2006; 40 (2): 145-50; discussion 145-50. (Pubitemid 43362459)
79. Huang S, Chen XH, Payne JR, et al. Haplotype of growth hormone and angiotensin I-converting enzyme genes, serum angiotensin I-converting enzyme and ventricular growth: pathway inference in pharmacogenetics. Pharmacogenet Genomics 2007; 17 (4): 291-4. (Pubitemid 46668053)
80. Berge KE, Bakken A, Bohn M, et al. A DNA polymorphism at the angiotensin II type 1 receptor (AT1R) locus and myocardial infarction. Clin Genet 1997; 52 (2): 71-6. (Pubitemid 27344785)
81. Diet F, Graf C, Mahnke N, et al. ACE and angiotensinogen gene genotypes and left ventricular mass in athletes. Eur J Clin Invest 2001; 31 (10): 836-42. (Pubitemid 34592082)
82. Delmonico MJ, Ferrell RE, Meerasahib A, et al. Blood pressure response to strength training may be influenced by angiotensinogen A-20C and angiotensin II type I receptor A1166C genotypes in older men and women. J Am Geriatr Soc 2005; 53 (2): 204-10. (Pubitemid 41632545)
83. Fatini C, Guazzelli R, Manetti P, et al. RAS genes influence exercise-induced left ventricular hypertrophy: an elite athletes study.Med Sci Sports Exerc 2000; 32 (11): 1868-72.
84. Bae JS, Kang BY, Lee KO, et al. Genetic variation in the renin-angiotensin system and response to endurance training. Med Princ Pract 2007; 16 (2): 142-6.
85. Hotta J, Hanaoka M, Droma Y, et al. Polymorphisms of renin-angiotensin system genes with high-altitude pulmonary edema in Japanese subjects. Chest 2004; 126 (3): 825-30. (Pubitemid 39258037)
86. Koehle MS, Wang P, Guenette JA, et al. No association between variants in the ACE and angiotensin II receptor 1 genes and acute mountain sickness in Nepalese pilgrims to the Janai Purnima Festival at 4380 m. High Alt Med Biol 2006; 7 (4): 281-9. (Pubitemid 46099760)
87. Houle S, Landry M, Audet R, et al. Effect of allelic polymorphism of the B(1) and B(2) receptor genes on the contractile responses of the human umbilical vein to kinins. J Pharmacol Exp Ther 2000; 294 (1): 45-51. (Pubitemid 30434669)
88. Lung CC, Chan EK, Zuraw BL. Analysis of an exon 1 polymorphism of the B2 bradykinin receptor gene and its transcript in normal subjects and patients with C1 inhibitor deficiency. J Allergy Clin Immunol 1997; 99 (1 Pt 1): 134-46. (Pubitemid 27074907)
89. Williams AG, Dhamrait SS, Wootton PT, et al. Bradykinin receptor gene variant and human physical performance. J Appl Physiol 2004; 96 (3): 938-42. (Pubitemid 38248666)
90. Saunders CJ, Xenophontos SL, Cariolou MA, et al. The bradykinin {beta}2 receptor (BDKRB2) and endothelial nitric oxide synthase 3 (NOS3) genes and endurance performance during ironman triathlons. Hum Mol Genet 2006; 15 (6): 979-87. (Pubitemid 43338238)
91. Yamin C, Amir O, Sagiv M, et al. ACE ID genotype affects blood creatine kinase response to eccentric exercise. J Appl Physiol 2007; 103 (6): 2057-61.
92. LiuY, Leri A, Li B, et al. Angiotensin II stimulation in vitro induces hypertrophy of normal and postinfarcted ventricular myocytes. Circ Res 1998; 82 (11): 1145-59.
93. Wollert KC, Drexler H. The renin-angiotensin system and experimental heart failure. Cardiovasc Res 1999; 43 (4): 838-49. (Pubitemid 29413183)
94. Danser AH, Saris JJ, Schuijt MP, et al. Is there a local renin-angiotensin system in the heart? Cardiovasc Res 1999; 44 (2): 252-65. (Pubitemid 29474088)
95. Schunkert H, Dzau VJ, Tang SS, et al. Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy: effects on coronary resistance, contractility, and relaxation. J Clin Invest 1990; 86 (6): 1913-20.
96. Beinlich CJ, White GJ, Baker KM, et al. Angiotensin II and left ventricular growth in newborn pig heart. J Mol Cell Cardiol 1991; 23 (9): 1031-8.
97. Schmieder RE, Martus P, Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension: a metaanalysis of randomized double-blind studies. JAMA 1996; 275 (19): 1507-13.
98. Cruickshank JM, Lewis J, Moore V, et al. Reversibility of left ventricular hypertrophy by differing types of antihypertensive therapy. J Hum Hypertens 1992; 6 (2): 85-90.
99. Schmieder RE, Schlaich MP, Klingbeil AU, et al. Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized doubleblind studies until December 1996). Nephrol Dial Transplant 1998; 13 (3): 564-9. (Pubitemid 28119033)
100. Buhl R, Ersboll AK, Eriksen L, et al. Changes over time in echocardiographic measurements in young standardbred racehorses undergoing training and racing and association with racing performance. J Am Vet Med Assoc 2005; 226 (11): 1881-7.
101. Young LE. Equine athletes, the equine athlete's heart and racing success. Exp Physiol 2003; 88 (5): 659-63. (Pubitemid 37121740)
102. Young LE, Rogers K, Wood JL. Left ventricular size and systolic function in thoroughbred racehorses and their relationships to race performance. J Appl Physiol 2005; 99 (4): 1278-85.
103. Montgomery HE, Clarkson P, Dollery CM, et al. Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation 1997; 96 (3): 741-7. (Pubitemid 27329604)
104. Di Mauro M, Izzicupo P, Santarelli F, et al. ACE and AGTR1 polymorphisms and left ventricular hypertrophy in endurance athletes.Med Sci Sports Exerc 2010; 42 (5): 915-21.
105. Kasikcioglu E, Kayserilioglu A, Ciloglu F, et al. Angiotensinconverting enzyme gene polymorphism, left ventricular remodeling, and exercise capacity in strength-trained athletes. Heart Vessels 2004; 19 (6): 287-93. (Pubitemid 39610379)
106. Hernandez D, de la Rosa A, Barragan A, et al. The ACE/DD genotype is associated with the extent of exercise- induced left ventricular growth in endurance athletes. J Am Coll Cardiol 2003; 42 (3): 527-32. (Pubitemid 36951722)
107. Lindpaintner K, Lee M, Larson MG, et al. Absence of association or genetic linkage between the angiotensinconverting-enzyme gene and left ventricular mass. N Engl J Med 1996; 334 (16): 1023-8.
108. Staessen JA, Wang JG, Ginocchio G, et al. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens 1997; 15 (12 Pt 2): 1579-92.
109. Yildiz A, Akkaya V, Hatemi AC, et al. No association between deletion-type angiotensin-converting enzyme gene polymorphism and left-ventricular hypertrophy in hemodialysis patients. Nephron 2000; 84 (2): 130-5. (Pubitemid 30081561)
110. Dursunoglu D, Evrengul H, Tanriverdi H, et al. Angiotensin-converting enzyme polymorphism in healthy young subjects: relationship to left ventricular mass and functions. Acta Cardiol 2005; 60 (2): 153-8. (Pubitemid 40835428)
111. Rizzo M, Gensini F, Fatini C, et al. ACE I/D polymorphism and cardiac adaptations in adolescent athletes. Med Sci Sports Exerc 2003; 35 (12): 1986-90.
112. Estacio RO, Jeffers BW, Havranek EP, et al. Deletion polymorphism of the angiotensin converting enzyme gene is associated with an increase in left ventricular mass in men with type 2 diabetes mellitus. Am J Hypertens 1999; 12 (6): 637-42. (Pubitemid 29268396)
113. Kuznetsova T, Staessen JA, Wang JG, et al. Antihypertensive treatment modulates the association between the D/I ACE gene polymorphism and left ventricular hypertrophy: a meta-analysis. J Hum Hypertens 2000; 14 (7): 447-54. (Pubitemid 30461932)
114. Yoneya K, Okamoto H, Machida M, et al. Angiotensinconverting enzyme gene polymorphism in Japanese patients with hypertrophic cardiomyopathy. Am Heart J 1995; 130 (5): 1089-93.
115. Dellgren G, Eriksson MJ, Blange I, et al. Angiotensinconverting enzyme gene polymorphism influences degree of left ventricular hypertrophy and its regression in patients undergoing operation for aortic stenosis. Am J Cardiol 1999; 84 (8): 909-13. (Pubitemid 29475075)
116. Ashley EA, Kardos A, Jack ES, et al. Angiotensin-converting enzyme genotype predicts cardiac and autonomic responses to prolonged exercise. J Am Coll Cardiol 2006; 48 (3): 523-31. (Pubitemid 44093938)
117. Tanriverdi H, Evrengul H, Kaftan A, et al. Effects of angiotensin-converting enzyme polymorphism on aortic elastic parameters in athletes. Cardiology 2005; 104 (3): 113-9. (Pubitemid 41291525)
118. Myerson SG,Montgomery HE, Whittingham M, et al. Left ventricular hypertrophy with exercise and ACE gene insertion/deletion polymorphism: a randomized controlled trial with losartan. Circulation 2001; 103 (2): 226-30. (Pubitemid 32095407)
119. Hallberg P, Lind L, Michaelsson K, et al. B2 bradykinin receptor (B2BKR) polymorphism and change in left ventricular mass in response to antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial. J Hypertens 2003; 21 (3): 621-4. (Pubitemid 36418975)
120. Brull D, Dhamrait S,Myerson S, et al. Bradykinin B2BKR receptor polymorphism and left-ventricular growth response. Lancet 2001; 358 (9288): 1155-6. (Pubitemid 32971851)
121. Folland J, Leach B, Little T, et al. Angiotensin-converting enzyme genotype affects the response of human skeletal muscle to functional overload. Exp Physiol 2000; 85 (5): 575-9.
122. Williams AG, Day SH, Folland JP, et al. Circulating angiotensin converting enzyme activity is correlated with muscle strength. Med Sci Sports Exerc 2005; 37 (6): 944-8. (Pubitemid 40847455)
123. Hopkinson NS, Nickol AH, Payne J, et al. Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 170 (4): 395-9. (Pubitemid 39214613)
124. Zhang B, Tanaka H, Shono N, et al. The I allele of the angiotensin-converting enzyme gene is associated with an increased percentage of slow-twitch type I fibers in human skeletal muscle. Clin Genet 2003; 63 (2): 139-44. (Pubitemid 36949910)
125. Caldiz CI, de Cingolani GE. Insulin resistance in adipocytes from spontaneously hypertensive rats: effect of long-term treatment with enalapril and losartan. Metabolism 1999; 48 (8): 1041-6.
126. Foianini KR, Steen MS, Kinnick TR, et al. Effects of exercise training and ACE inhibition on insulin action in rat skeletal muscle. J Appl Physiol 2000; 89 (2): 687-94. (Pubitemid 30637119)
127. Henriksen EJ, Jacob S. Effects of captopril on glucose transport activity in skeletal muscle of obese Zucker rats. Metabolism 1995; 44 (2): 267-72.
128. Linz W, Wiemer G, Scholkens BA. Role of kinins in the pathophysiology of myocardial ischemia: in vitro and in vivo studies. Diabetes 1996; 45 Suppl. 1: S51-8. (Pubitemid 26011990)
129. Wicklmayr M, Dietze G, Gunther B, et al. The kallikreinkinin system and muscle metabolism-clinical aspects. Agents Actions 1980; 10 (4): 339-43. (Pubitemid 11195277)
130. Taguchi T,Kishikawa H, Motoshima H, et al. Involvement of bradykinin in acute exercise-induced increase of glucose uptake and GLUT-4 translocation in skeletal muscle: studies in normal and diabetic humans and rats. Metabolism 2000; 49 (7): 920-30. (Pubitemid 30483447)
131. Hopkinson NS, Eleftheriou KI, Payne J, et al. +9/+9 Homozygosity of the bradykinin receptor gene polymorphism is associated with reduced fat-free mass in chronic obstructive pulmonary disease. Am J Clin Nutr 2006; 83 (4): 912-7. (Pubitemid 44713158)
132. Wagner H, Thaller S, Dahse R, et al. Biomechanical muscle properties and angiotensin-converting enzyme gene polymorphism: a model-based study. Eur J Appl Physiol 2006; 98 (5): 507-15. (Pubitemid 44873309)
133. Montgomery H, Clarkson P, BarnardM, et al. Angiotensinconverting-enzyme gene insertion/deletion polymorphism and response to physical training. Lancet 1999; 353 (9152): 541-5. (Pubitemid 29078424)
134. Heled Y, Moran DS, Mendel L, et al. Human ACE I/D polymorphism is associated with individual differences in exercise heat tolerance. J Appl Physiol 2004; 97 (1): 72-6. (Pubitemid 38802504)
135. Tanriverdi H, Evrengul H, Tanriverdi S, et al. Improved endothelium dependent vasodilation in endurance athletes and its relation with ACE I/D polymorphism. Circ J 2005; 69 (9): 1105-10.
136. Dengel DR, Brown MD, Ferrell RE, et al. Exercise-induced changes in insulin action are associated with ACE gene polymorphisms in older adults. Physiol Genomics 2002; 11 (2): 73-80.
137. Woods DR, Montgomery HE. Angiotensin-converting enzyme and genetics at high altitude. High Alt Med Biol 2001; 2 (2): 201-10. (Pubitemid 32677858)
138. Kalson N, Thompson J, Davies A, et al. The effect of angiotensin- converting enzyme genotype on acute mountain sickness and summit success in trekkers attempting the summit of Mt. Kilimanjaro (5,895 m). Eur J Appl Physiol 2009; 105 (3): 373-9.
139. Dehnert C, Weymann J, Montgomery HE, et al. No association between high-altitude tolerance and the ACE I/D gene polymorphism. Med Sci Sports Exerc 2002; 34 (12): 1928-33.
140. Qi Y, Niu W, Zhu T, et al. Synergistic effect of the genetic polymorphisms of the renin-angiotensin-aldosterone system on high-altitude pulmonary edema: a study from Qinghai-Tibet altitude. Eur J Epidemiol 2008; 23 (2): 143-52.
141. Droma Y, Hanaoka M, Basnyat B, et al. Adaptation to high altitude in sherpas: association with the insertion/deletion polymorphism in the angiotensin-converting enzyme gene. Wilderness Environ Med 2009; 19 (1): 22-9. (Pubitemid 351430072)
142. Patel S, Woods DR, Macleod NJ, et al. Angiotensinconverting enzyme genotype and the ventilatory response to exertional hypoxia. Eur Respir J 2003; 22 (5): 755-60. (Pubitemid 37369563)
143. Woods DR, Pollard AJ, Collier DJ, et al. Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene and arterial oxygen saturation at high altitude. Am J Respir Crit Care Med 2002; 166 (3): 362-6. (Pubitemid 34864427)
144. Bigham AW, Kiyamu M, Leó n-Velarde F, et al. Angiotensin- converting enzyme genotype and arterial oxygen saturation at high altitude in Peruvian Quechua. High Alt Med Biol 2008; 9 (2): 167-78. (Pubitemid 351913536)
145. Qadar Pasha MA, Khan AP, Kumar R, et al. Angiotensin converting enzyme insertion allele in relation to high altitude adaptation. Ann Hum Genet 2001; 65 (6): 531-6. (Pubitemid 34163116)
146. Gonzalez AJ, Hernandez D, De Vera A, et al. ACE gene polymorphism and erythropoietin in endurance athletes at moderate altitude. Med Sci Sports Exerc 2006; 38 (4): 688-93.
147. Heled Y, Bloom MS, Wu TJ, et al. CK-MM and ACE genotypes and
148. Di Bari M, van de Poll-Franse LV, Onder G, et al. Antihypertensive medications and differences in muscle mass in older persons: the Health, Aging and Body Composition Study. J Am Geriatr Soc 2004; 52 (6): 961-6. (Pubitemid 38789068)
149. Levine BD. . VO2max: what do we know, and what do we still need to know? J Physiol 2008; 586 (1): 25-34.
150. Hagerman FC, Connors MC, Gault JA, et al. Energy expenditure during simulated rowing. J Appl Physiol 1978; 45 (1): 87-93. (Pubitemid 9182889)
151. Abraham MR, Olson LJ, Joyner MJ, et al. Angiotensinconverting enzyme genotype modulates pulmonary function and exercise capacity in treated patients with congestive stable heart failure. Circulation 2002; 106 (14): 1794-9.
152. Hagberg JM, Ferrell RE, McCole SD, et al. . VO2 max is associated with ACE genotype in postmenopausal women. J Appl Physiol 1998; 85 (5): 1842-6.
153. Roltsch MH, Brown MD, Hand BD, et al. No association between ACE I/D polymorphism and cardiovascular hemodynamics during exercise in young women. Int J Sports Med 2005; 26 (8): 638-44. (Pubitemid 41426813)
154. Woods DR, World M, Rayson MP, et al. Endurance enhancement related to the human angiotensin I-converting enzyme I-D polymorphism is not due to differences in the cardiorespiratory response to training. Eur J Appl Physiol 2002; 86 (3): 240-4. (Pubitemid 36067477)
155. Bouchard C, Rankinen T, Chagnon YC, et al. Genomic scan for maximal oxygen uptake and its response to training in the HERITAGE Family Study. J Appl Physiol 2000; 88 (2): 551-9. (Pubitemid 30097098)
156. Bouchard C, Leon AS, Rao DC, et al. The HERITAGE family study: aims, design, and measurement protocol. Med Sci Sports Exerc 1995; 27 (5): 721-9.
157. Zhang X, Wang C, Dai H, et al. Association between angiotensin-converting enzyme gene polymorphisms and exercise performance in patients with COPD. Respirology 2008; 13 (5): 683-8. (Pubitemid 351977595)
158. Kanazawa H, Otsuka T, Hirata K, et al. Association between the angiotensin-converting enzyme gene polymorphisms and tissue oxygenation during exercise in patients with COPD. Chest 2002; 121 (3): 697-701. (Pubitemid 34251430)
159. Defoor J, Vanhees L, Martens K, et al. The CAREGENE study: ACE gene I/D polymorphism and effect of physical training on aerobic power in coronary artery disease. Heart 2006; 92 (4): 527-8.
160. Welsby IJ, Podgoreanu MV, Phillips-Bute B, et al. Genetic factors contribute to bleeding after cardiac surgery. J Thromb Haemost 2005; 3 (6): 1206-12.
161. Harding D, Baines PB, Brull D, et al. Severity of meningococcal disease in children and the angiotensin-converting enzyme insertion/deletion polymorphism. Am J Respir Crit Care Med 2002; 165 (8): 1103-6.
162. Wang P, Fedoruk MN, Rupert JL. Keeping pace with ACE: are ACE inhibitors and angiotensin II type 1 receptor antagonists potential doping agents? Sports Med 2008; 38 (12): 1065-79